The authors sought to risk stratify pts with secondary TR and then analyze outcomes of different treatment options for TR in conjunction with repair of left-sided valve disease. Low risk patients did well without TR intervention, intermediate risk patients did well with De Vega annuloplasty, and high risk patients fitted with an undersized annulopla
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cardiac
October 8, 2015
October 8, 2015
The effects of renal failure on outcomes of AVR were examined using CMS data. TAVR pts on dialysis, TAVR pts not on dialysis, and surgical AVR pts on dialysis were compared after propensity score matching. In TAVR patients, dialysis was associated with increased 30 day mortality and survival, and was an independent predictor of worse survival. TAV
October 6, 2015
This video demonstrates a Florida sleeve valve-sparing aortic root repair, repair of the leaking bicuspid valve with raphe shaving, virtual basal ring annuloplasty and leaflet plication, and ascending through proximal arch replacement with alternate aortic cannulation/clamping.
October 5, 2015
Pts undergoing cardiac surgery requiring CPB were randomized to remote ischemic preconditioning of the upper extremity or sham intervention. The end point was combined death, MI, stroke, and acute renal failure during hospitalization, and secondary endpoints were the occurrence of any such event within 90 days. Outcomes were similar between the gro
October 5, 2015
Pts undergoing CABG on-pump were randomized to remote preconditioning (upper arm ischemia) or sham intervention prior to surgical incision. The primary end point was a combination of cardiovascular death, stroke, MI, and revascularization. At 1 year there was no difference between the groups in the incidence of the end point, and other important cl
October 5, 2015
Patients entered into a clinical trial of TAVR and patients in two registries were evaluated for possible subclinical leaflet thrombosis in their bioprosthetic valves. 40% of the patients in the TAVR trial and 13% of registry patients were found to have such thrombosis. The risk was lower in patients anticoagulated with warfarin. Therpeutic antico
October 4, 2015
European Association for Cardio-Thoracic Surgery (EACTS) Past President Jose Pomar interviews current President Martin Grabenwoger on key features of the 2015 EACTS Annual Meeting.
October 3, 2015
Pieter Kappetein, Secretary General of the European Association for Cardio-Thoracic Surgery (EACTS), previews the 2015 EACTS Annual Meeting taking place in Amsterdam, The Netherlands.
September 30, 2015
Ischemic mitral regurgitation (IMR) is a subset of functional mitral regurgitation (MR) that has the potential to impact an increasing number of patients in the future. This is in the context of a worldwide population, which continues to live longer with improved survival after myocardial infarction.
September 30, 2015
In an interview filmed at the 2015 STS Annual Meeting in San Diego, California, Tom Nguyen speaks with Michael Reardon, Chief of Cardiac Surgery at the Methodist DeBakey Heart & Vascular Center in Houston, TX.